Evaluation of PSMA target diagnostic PET tracers for therapeutic monitoring of [177Lu]ludotadipep of prostate cancer: Screening of PSMA target efficiency and biodistribution using [18F]DCFPyL and [68Ga]PSMA-11-Reference-Cited by-同舟云学术

Evaluation of PSMA target diagnostic PET tracers for therapeutic monitoring of [177Lu]ludotadipep of prostate cancer: Screening of PSMA target efficiency and biodistribution using [18F]DCFPyL and [68Ga]PSMA-11

Published:2023-04 Issue: Volume:651 Page:107-113
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Kim Min Hwan^ORCID,Lee Kyongkyu^ORCID,Oh Keumrok^ORCID,Kim Chul Hee^ORCID,Kil Hee Seup^ORCID,Lee Yong Jin^ORCID,Lee Kyo Chul,Chi Dae Yoon^ORCID

Funder

Korea Institute of Radiological & Medical Sciences

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference14 articles.

1. Improving theranostic Gallium-68/Lutetium-177-labeled PSMA inhibitors with an albumin binder for prostate cancer;Lee;Mol. Cancer Therapeut.,2021

2. A single dose of novel PSMA-targeting radiopharmaceutical agent [177Lu]ludotadipep for patients with metastatic castration-resistant prostate;Shin;Cancers,2022

3. A phase 2/3 prospective multicenter study of the diagnostic accuracy of prostate specific membrane antigen PET/CT with 18F-DCFPyL in prostate cancer patients (OSPREY);Pienta;J. Urol.,2021

4. [68Ga]Ga-PSMA-11: the first FDA-approved 68Ga-radiopharmaceutical for PET imaging of prostate cancer;Hennrich;Pharmaceuticals,2021

5. 18F-Labeled 1,2,3-Triazole-linked Glu-urea-Lys-based PSMA ligands have good pharmacokinetic properties for positron emission tomography imaging of prostate cancer;Lee;Prostate,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PET Molecular Imaging: Old Habits Do Not Die, They Only Evolve into New Applications;International Journal of Molecular Sciences;2023-12-28